
BioConnect
BioConnect is a cybersecurity company specializing in IAM, founded in 2010 and headquartered in Toronto, Canada. It has raised $1.5M debt & credit · $3.9M non-dilutive & grants, with no priced equity round on record, employs about 36 people, and was acquired by Gentex in 2025.
updated Oct 1, 2026
Latest BioConnect news and company activity
What BioConnect did, dated — selected moves from the record, one per kind, newest first.
- Nov 2025AcquiredGentex Announces Acquisition of BioConnect
1 event tracked since Nov 2025 · selected events shownUnlock the complete BioConnect timeline
BioConnect Momentum score
38/ 100
Mandos Momentum blends hiring, funding, traffic and sentiment into one score out of 100. The score is free; the pillars behind it unlock in the platform.
BioConnect funding
BioConnect has no priced equity round on record. It has raised $1.5M debt & credit · $3.9M non-dilutive & grants. Its most recent round was a Debt Financing in July 2020.
- Last round
- Debt FinancingJul 2020
- Other instruments
- $1.5M debt · $3.9M non-dilutive
BioConnect employees and hiring
BioConnect competitors
Security professionals most often compare BioConnect against AuthenTrend on cybersectools.com. The full competitive set, with overlap scoring, is in the platform.
by search demand for comparison pages on cybersectools.com, 90 days
The other 440 data points.
- Funding historyevery round, every investor named
- Headcount growthvelocity, departments, seniority
- Open jobslive postings, hiring pace, role mix
- Tech stackframeworks, clouds, security



